Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment

Drugs and Aging

Volumn 9, Issue 5, 1996, Pages 341-351

  Ailabouni, Wadad ^a   Eknoyan, Garabed ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOPROFEN; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIRPROFEN; TOLMETIN;

ACUTE KIDNEY FAILURE; AGED; AGING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0029966190     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199609050-00005     Document Type: Review

References (74)

1. Roy FH, Russel C, editors. The encyclopedia of aging and the elderly. New York: Facts on File, 1992: 48-9
2. Jones AC, Berman P, Doherty M. Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions. Br J Rheumatol 1980; 31: 45-8
3. Henry D, Dohson A, Turner C, et al. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078-88
4. Eknoyan G. Tubulointerstitial nephropathies. In: Martinez-Maldonado M, editor. Hypertension and renal disease in the elderly. Boston: Blackwell Scientific Publications. 1992: 225-41
5. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984; 26: 861-8
6. Lindeman RD. Hypertension and the kidney. Nephron 1987; 47 Suppl. 1:62-7
7. Riser BL, Cortes P, Zhao X, et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90: 1932-43
8. McDonald RK, Solomon DH, Shock NW. Aging as a factor in the renal hemodynamic changes induced by standardized pyrogen. J Clin Invest 1951; 5: 457-62
9. Pelz KS, Gottfried PE. Kidney function studies in old men and women. Geriatrics 1965; 20: 145-9
10. McLachlan MSF. The aging kidney. Lancet 1978; 11: 143-6
11. Epstein M. Effects of aging on the kidney. Fed Proc 1979; 38: 168-72
12. Brown W, Davis BB, Apry LA, et al. Aging and the kidney. Arch Intern Med 1986; 146: 1790-6
13. Anderson S, Brenner BM. The aging kidney: structure, function, mechanisms and therapeutic implications. J Am Geriatr Soc 1987; 35: 590-3
14. Beck LE. Kidney function and disease in the elderly. Hosp Pract 1988; 15: 75-90
15. Darmady EM, Offer J, Woodhouse MA. The parameters of the aging kidney. J Pathol 1973; 109: 195-207
16. Sworn MJ, Fox M. Renal age change in the rat compared with human renal senescence: an autoradiography study. Invest Urol 1974; 12: 140-5
17. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal kidney, related to age and sex. Virchows Arch A Pathol Anat Histopathol 1980; 387: 271-7
18. Haley DP, Bulger RE. The aging male rat: structure and function of the kidney. Am J Anat 1983; 167: 1-13
19. Lindeman RD, Lee TD, Yiengst MJ, et al. Influence of age, renal disease, hypertension, diuretics, and calcium on the antidiuretic responses to suboptimal infusions of vasopressin. J Lab Clin Med 1966; 68: 206-22
20. Epstein M, Hollenberg NM. Age as a determinant of oral sodium conservation in normal man. J Lab Clin Med 1976; 87: 411-2
21. Adler S, Lindeman RD, Yiengst MJ, et al. Effect of acute acid loading on urinary acid excretion of the aging human kidney. J Lab Clin Med 1968; 72: 278-89
22. Davies DF, Shock NW. Age changes in glomerular filtration, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-507
23. Miller JH, McDonald RK, Shock NW. Age changes in the maximal rate of renal tubular reabsorption of glucose. J Gerontol 1952; 7: 196-200
24. Eknoyan G. Current status of chronic analgesic and nonsteroidal antiinflammatory drug nephropathy. Curr Opin Nephrol Hypertens 1994; 3: 182-8
25. Murray M, Black P, Kuzmik D, et al. Acute and chronic effects of NSAIDs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 31 (5): 188-97
26. Brater DC, Anderson SA, Brown-Cartwright D, et al. Effect of etodolac in patients with moderate renal impairment compared with normal subjects. Clin Pharmacol Ther 1985; 38: 674-9
27. Toto RD, Anderson SA, Brown-Cartwright D, et al. Effects of acute and chronic NSAIDs in patients with renal insufficiency. Kidney Int 1986; 80: 760-8
28. Murray MD, Green PK, Brater DC, et al. Effects of flurbiprofen on renal function in patients with moderate renal insufficiency. Br J Clin Pharmacol 1992; 33: 386-93
29. Carmichael J, Shankel SW. Effects of non-steroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985; 78: 992-1000
30. Kjellstrand C, Leither T, Koehn J, et al. latrogenic renal disease. Arch Intern Med 1991; 151: 1809-12
31. Eknoyan G. Acute renal failure associated with tubulointerstitial nephropathies. In: Brenner BM, Lazarus JM, editors. Acute renal failure. 2nd ed. New York: Churchill Livingston. 1988: 491-534
32. Porile J, Bakris G, Garella S. Acute interstitial nephritis with glomerulopathy due to NSAID agents: a review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol 1990; 30: 468-75
33. Radford Jr MG, Holley KE, Grande JP, et al. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 1996 Aug 14; 276: 466-9
34. Palmer BF. Renal complications associated with non-steroidal anti-inflammatory agents. J Invest Med 1995; 43 (6): 516-32
35. D'Elia J, Merino M, Rolla A, et al. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen. Ann Intern Med 1980; 92: 72-3
36. Seelig C, Maloley P, Campbell J. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. South Med J 1990; 83 (10): 1144-7
37. Clark BA, Shannon RP, Rosa RM, et al. Increased susceptibility to thiazine-induced hyponatremia in the elderly. J Am Soc Nephrol 1994; 5: 1106-11
38. Lamiere N, Matthys E, Vanholder R, et al. Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant 1987; 2: 316-22
39. Fullerton T, Sica D, Blum R. Evaluation of the renal protective effect of misoprostol in elderly osteoarthritic patients at risk for NSAID-induced renal dysfunction. J Clin Pharmacol 1993; 33: 1225-32
40. Boers M, Dijkmans BAC, Breedveld FC, et al. No effect of misoprostol on renal function of rheumatoid patients treated with diclofenac. Br J Rheum 1991; 30: 56-9
41. Anlillon M, Cominelli F, Lo S, et al. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. J Rheumatol 1990; 17: 46-9
42. Whelton A, Strout R, Spilman P, et al. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990; 112: 568-76
43. Simon LS, Basch CM, Young DY, et al. Effects of naproxen on renal function in older patients with mild to moderate renal dysfunction. Br J Rheumatol 1992; 31: 163-8
44. Eriksson LO, Sturfelt G, Thysell H, et al. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med 1990; 89: 313-21
45. Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983; 143: 1130-4
46. Hale W, May F, Marks R, et al. Renal effects of NSAIDs in the elderly. Curr Ther Res 1989; 46 (1): 173-9
47. Swainson CP, Griffiths P, Watson ML. Chronic effects of oral sulindac on renal haemodynamics and hormones in subjects with chronic renal disease. Clin Sci 1986 Mar; 70 (3): 243-7
48. Ciabattoni G, Cinotti G, Pierucci A, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 1984; 310: 279-83
49. Quintero E, Gines P, Arroyo V, et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 1986; 42: 298-303
50. Schnitzer T, Moskowitz R, Griffin M, et al. Guidelines for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 1995; 38: 1535-46
51. Henrieh WL, Agodoa LE, Barrett B, et al. National Kidney Foundation Position Paper. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 1996; 27: 162-5
52. Wendland M, Wagoner R, Holley VS. Renal failure associated with fenoprofen. Mayo Clin Proc 1980; 55: 103-7
53. Fienfeld D, Olesnicky L, Pirani C, et al. Nephrotic syndrome associated with use of NSAIDs. Nephron 1984; 37: 174-9
54. Brezin J, Moriherkatz S, Schwartz A, et al. Reversible renal failure and nephrotic syndrome associated with NSAIDs. N Engl J Med 1979; 301: 1271-3
55. Finkelstein A, Fraley D, Stachura J, et al. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. Am J Med 1982; 72: 81-7
56. Handa P. Renal effects of fenoprofen [letter]. Ann Intern Med 1980; 93; 508
57. Hannedouche T, Fournier J, Moore N, et al. Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen [letter]. Clin Nephrol 1986; 25: 314
58. Furey S, Vargas R, McMahon F. Renovascular effects of non-prescription ibuprofen in elderly hypertensive patients with renal impairment. Pharmacotherapy 1993; 13: 143-8
59. Gurwitz J, Avorn J, Degnan D, et al. Nonsteroidal anti-inflammatory drug associated azotemia in the very old. JAMA 1990; 264 (4): 471-5
60. Murray M, Brater C, Tierney W, et al. Ihuprofen associated renal impairment in a large general internal medicine practice. Am J Med Sci 1990; 299 (4): 222-9
61. Kharasch M, Johnson K, Strange G, Cardiac arrest secondary to indomethacin-induced renal failure: a case report. J Emerg Med 1990; 8: 51-4
62. Tan SY, Shapiro R, Kish MA. Reversible acute renal failure induced by indomethacin. JAMA 1979; 241: 2732-3
63. Fawaz-Estrup F, Ho Jr G. Reversible acute renal failure induced by indomethacin. Arch Intern Med 1981; 141: 1670-1
64. Galler M, Folkert VW, Schlondorff DO. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA 1981; 246: 154-5
65. MacCarthy EP. Indomethacin-induced hyperkalemia. Med J Aust 1979; 1: 550
66. Kimberly RP, Brandstetter RD. Exacerbation of phenylbutaz one related renal failure by indomethacin. Arch Intern Med 1978; 138: 1711-2
67. Schoch P, Ranno A, North D. Acute renal failure in an elderly woman following intramuscular ketorolac administration Ann Pharm 1992; 26: 1233-5
68. Adverse Drug Reactions Advisory Committee. Ketorolac and renal failure. Med J Aust 1993; 159: 488
69. Pearce C, Gonzalez FM, Wallin D. Renal failure and hyperkalemia associated with ketorolac. Arch Intern Med 1993; 53: 1000-2
70. Boras-Uber L, Brackett N. Ketorolac induced acute renal failure. Am J Med 1992; 92: 450-2
71. Haragsim L, Dalal R, Baffa H, et al. Ketorolac induced acute renal failure and hyperkalemia: report of 3 cases. Am J Kidney Dis 1994; 24: 578-80
72. Perazella M, Bulla G. NSAID nephrotoxicity revisited: acute renal failure due to parenteral ketorolac. South Med J 1993; 86: 1421-4
73. Corelli R, Gericke K. Renal insufficiency associated with intramuscular administration of ketorolac. Ann Pharmacother 1993; 27: 1055-7
74. Fong J, Gora M. Reversible renal insufficiency following ketorolac therapy. Ann Pharmacother 1993; 27: 510-2